We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Hatch, Walden Urge OMB to Analyze Effects of Drug Rebate Reform on Industry
Hatch, Walden Urge OMB to Analyze Effects of Drug Rebate Reform on Industry
Sen. Orrin Hatch (R-Utah) and Rep. Greg Walden (R-Ore.) urged the Office of Management and Budget (OMB) to consider the potential fallout from the White House’s proposed rule that would remove drugmakers’ anti-kickback protections for prescription drug rebates.